Literature DB >> 17087699

Low alanine aminotransferase activity in older people is associated with greater long-term mortality.

Eran Elinav1, Zvi Ackerman, Yoram Maaravi, Iddo Z Ben-Dov, Eliana Ein-Mor, Jochanan Stessman.   

Abstract

OBJECTIVES: To find possible association between liver enzymes and mortality in older people.
DESIGN: A prospective cohort study.
SETTING: Jerusalem. PARTICIPANTS: A systematically selected representative sample of 455 70-year-old ambulatory individuals was prospectively followed for 12 years. MEASUREMENTS: An extensive social and medical profile was developed at age 70 using a detailed interview and physical and ancillary examination. Information on mortality was obtained annually. Differences in survival between subjects stratified according to liver enzyme levels were assessed using the Kaplan-Meier method. Multivariable survival analyses using a Cox proportional hazards model were performed to determine the association between liver enzyme levels at age 70 and mortality over 12 years.
RESULTS: Median alanine aminotransferase (ALT) activity of the study population was 11.00 U/L for women and 13.00 U/L for men. Twelve-year survival rates for women with ALT below and above the median levels were similar (78%). For men, these rates were 54% and 65%, respectively (P < .001). Proportional hazards models demonstrated that this greater mortality risk was independent of numerous common risk factors for mortality (hazard ratio (HR) = 1.5, 95% confidence interval (CI) = 1.08-2.19). Adding an interaction between sex and low ALT to the model demonstrated a higher risk of mortality for men with low ALT levels (HR = 2.42, 95% CI = 1.15-5.08). No such risk was demonstrated for the other liver enzymes.
CONCLUSION: ALT activity represents a strong and independent surrogate marker for mortality in community-dwelling elderly men.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17087699     DOI: 10.1111/j.1532-5415.2006.00921.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  33 in total

1.  Low Alanine Aminotransferase Levels in the Elderly Population: Frailty, Disability, Sarcopenia, and Reduced Survival.

Authors:  Umberto Vespasiani-Gentilucci; Antonio De Vincentis; Luigi Ferrucci; Stefania Bandinelli; Raffaele Antonelli Incalzi; Antonio Picardi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-06-14       Impact factor: 6.053

2.  The association of low serum alanine aminotransferase activity with mortality in the US population.

Authors:  Constance E Ruhl; James E Everhart
Journal:  Am J Epidemiol       Date:  2013-09-26       Impact factor: 4.897

3.  The Framingham risk score and heart disease in nonalcoholic fatty liver disease.

Authors:  Sombat Treeprasertsuk; Scott Leverage; Leon A Adams; Keith D Lindor; Jennifer St Sauver; Paul Angulo
Journal:  Liver Int       Date:  2012-02-02       Impact factor: 5.828

4.  Atherosclerosis and Liver Function Tests in Coronary Angiography Patients.

Authors:  Y C Doganer; J E Rohrer; U Aydogan; D C Agerter; T Cayci; C Barcin
Journal:  West Indian Med J       Date:  2015-05-08       Impact factor: 0.171

5.  A Comparison of Two Mouse Frailty Assessment Tools.

Authors:  Alice E Kane; Aniko Huizer-Pajkos; John Mach; Sarah J Mitchell; Rafael de Cabo; David G Le Couteur; Susan E Howlett; Sarah N Hilmer
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-07-01       Impact factor: 6.053

6.  Serum levels of alanine aminotransferase decrease with age in longitudinal analysis.

Authors:  Mamie H Dong; Ricki Bettencourt; David A Brenner; Elizabeth Barrett-Connor; Rohit Loomba
Journal:  Clin Gastroenterol Hepatol       Date:  2011-10-20       Impact factor: 11.382

7.  The association of alanine transaminase with aging, frailty, and mortality.

Authors:  David G Le Couteur; Fiona M Blyth; Helen M Creasey; David J Handelsman; Vasi Naganathan; Philip N Sambrook; Markus J Seibel; Louise M Waite; Robert G Cumming
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-05-24       Impact factor: 6.053

8.  Alanine aminotransferase decreases with age: the Rancho Bernardo Study.

Authors:  Mamie H Dong; Ricki Bettencourt; Elizabeth Barrett-Connor; Rohit Loomba
Journal:  PLoS One       Date:  2010-12-08       Impact factor: 3.240

Review 9.  Drug-induced liver injury in older adults.

Authors:  Sarah J Mitchell; Sarah N Hilmer
Journal:  Ther Adv Drug Saf       Date:  2010-12

10.  The association between serum liver enzymes and cancer mortality.

Authors:  Somaya Albhaisi; Rehan Qayyum
Journal:  Clin Exp Med       Date:  2021-07-08       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.